Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

Paleontologist Caleb Brown said that the fossil is "exceptionally uncommon"—not least because the pterosaur was a juvenile.

Spinraza generated worldwide sales of $1.15 billion for the first nine months of 2024. Biogen licensed the global rights to develop, manufacture and commercialize Spinraza from Ionis Pharmaceuticals, ...

Bo Nix’s back injury can cause “some of the worst pain,” but there’s no long-term sequela, according to Dr. Payal Kohli.